Eagle Pharmaceuticals, Inc. (EGRX)

Eagle Pharmaceuticals Revenue

Eagle Pharmaceuticals had revenue of $64.65M in the quarter ending June 30, 2023, a decrease of -12.80%. This brings the company's revenue in the last twelve months to $257.55M, down -5.38% year-over-year. In the year 2022, Eagle Pharmaceuticals had annual revenue of $316.61M with 84.56% growth.

• Revenue (ttm): 257.55M
• Revenue Growth: -5.38%
• P/S Ratio: 0.05
• Revenue / Employee: 1.92M
• Employees: 134
• Market Cap: 13.35M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	316.61M	145.06M	84.56%
Dec 31, 2021	171.55M	-16.26M	-8.66%
Dec 31, 2020	187.80M	-8.09M	-4.13%
Dec 31, 2019	195.89M	-17.42M	-8.17%
Dec 31, 2018	213.31M	-23.40M	-9.88%

Data Source: S&P Global Market Intelligence Last updated: Aug 8, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 26, 2026

Data Sources Report a data error